GlaxoSmithKline (GSK) to Close U.K. Research Center - DJN
More News related to GSK
- Ligand Pharma (LGND) Announces that Glaxo (GSK) was Approved for Revolade Marketing in Europe
- Ligand Announces Approval for Revolade(R) in Europe
- Piper Jaffray Assumes Coverage on Human Genome Sciences (HGSI) with an Overweight; Benlysta's First Mover Advantage Key to $4bn+ Opportunity
- GlaxoSmithKline (GSK) ANnoujnces Sale of Entire Holding in Maxygen (MAXY)
- Organization Representing Minority and Women Owned Law Firms Praises $30 Million Corporate Commitment
More News related to General News
- Trichet Comments On Greece, Inflation, the Euro vs Dollar and EMF
- Janet Yellen Expected To Be Tapped as Federal Reserve Vice Chairman
- Pre-Market Indices - DJIA Up 34, NASDAQ Up 4.75, S&P 500 Up 4.75
- E*Trade (ETFC) Calls Lindsay Lohan Suit Without Merit
- HSBC Employee Steals Info from 24,000 Swiss Bank Accounts
According to a Dow Jones Newswire, GlaxoSmithKline (NYSE: GSK) is to shutter a U.K. research center following the completion of a study on pain relief, anxiety, and depression.
The loss of jobs would amount to about 380.
Related Categories
General NewsStocks Mentioned
-0.02Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
